Delivery Order SPE2DB22D2006-SPE2DB25FV9YS

Award Date 4/13/25
Potential Completion Date 4/14/25
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,624.00, is for the supply of INFED 100 MG/2 ML VIAL 2ML, a medical product. The contract has a firm fixed price and a completion date of February 5, 2025. This award is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $4,789.62, is for the delivery of 4564212126 - INFED 100 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract is a task order issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of INFED 100 MG/2 ML VIAL 2ML, a pharmaceutical product, with a ceiling value of $2,177.10 and a period of performance through March 20, 2024. Amerisourcebergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) with DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of INFED 100 MG/2 ML VIAL 2ML pharmaceutical products. The total ceiling value of the contract is $8,055.27, and the ultimate completion date is April 16, 2024. Amerisourcebergen, a major pharmaceutical distribution company, is the prime contractor for this award. The contract does not have a...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) Troop Support to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier. The $2,177 firm fixed price delivery order is for the supply of INFED 100 MG/2 ML VIAL 2ML, a medical product, with a completion date of September 12, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued at up...
This federal contract award is for the delivery of INFED 100MG/2ML VI 10S pharmaceutical products to the Medical Supply Chain organization, a component of the Defense Logistics Agency (DLA). The $12,895.54 firm fixed-price delivery order contract has an ultimate completion date of September 6, 2024 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 9, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $17,825.97, is for the delivery of medical supplies, specifically 4567741438 ! INFED 100MG/2ML VI 10S. The contract has an ultimate completion date of April 25, 2025 and was awarded on March 31, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $8,901.48 Firm Fixed Price Delivery Order is for the supply of INFED 100 MG/2 ML VIAL 2ML, a pharmaceutical product. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract has a ceiling value of $3,382.06 and is for the delivery of pharmaceutical products and medical supplies, including a specific item described as "4564519704 ! INFED 100MG/2ML VI 10S." The contract does not have a set-aside designation and is a Firm Fixed Price contract. Amerisourcebergen Drug...
The Defense Logistics Agency Troop Support Medical awarded a $1,274 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561328220 INFED 100 MG/2 ML VIAL 2ML. The place of performance is Conshohocken, Pennsylvania. The period of performance is from June 23, 2023 through June 26, 2023. No additional details were provided regarding the original solicitation or any overarching contracts under which this delivery order was issued. Amerisourcebergen Drug Corporation will fulfill...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV9YS
    Delivery Order

This is a $2,876.54 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of 4567893692 INFED 100 MG/2 ML VIAL 2ML and has an ultimate completion date of April 14, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/13/25, 9:42 AM